Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Terminated 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

apalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Low Risk Prostate Cancer × Clear all
NCT01877070 2026-05-06

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Memorial Sloan Kettering Cancer Center

Active not recruiting
541 enrolled
Genitourinary

Low Risk Prostate Cancer

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed
93 enrolled
Genitourinary

Low Risk Prostate Cancer

NCT03740191 2025-05-11

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

EBG MedAustron GmbH

Phase NA Terminated
5 enrolled
Genitourinary

Low Risk Prostate Cancer

NCT03849365 2021-03-23

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

Steba Biotech S.A.

Phase 4 Terminated
23 enrolled
Genitourinary

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡